Litcius/Paper detail

Simultaneous enhancement of T<sub>1</sub> and T<sub>2</sub> magnetic resonance imaging of liver tumor at respective low and high magnetic fields

Huan Li, Zijuan Hai, Liwei Zou, Lele Zhang, Lulu Wang, Longsheng Wang, Gaolin Liang

2021Theranostics32 citationsDOIOpen Access PDF

Abstract

Background: Nowadays, magnetic resonance imaging (MRI) is routinely applied in clinical diagnosis. However, using one contrast agent (CA) to simultaneously enhance the T 1 and T 2 MR contrast at low and high magnetic fields respectively has not been reported. Methods: Herein, we investigated the MR property of a -glutamyl transpeptidase (GGT)-instructed, intracellular formed gadolinium nanoparticle (DOTA-Gd-CBT-NP) at low and high magnetic fields. Results: Experimental results showed that DOTA-Gd-CBT-NP possesses a low r 2 /r 1 ratio 0.91 which enables it to enhance T 1 MR imaging of liver tumor at 1.0 T, and a high r 2 /r 1 ratio 11.8 which renders the nanoparticle to largely enhance T 2 MR imaging of liver tumor at 9.4 T.

Topics & Concepts

Magnetic resonance imagingGadoliniumNuclear magnetic resonanceLiver cancerMRI contrast agentNanoparticleNuclear medicineLiver tumorMaterials scienceMedicineChemistryRadiologyHepatocellular carcinomaNanotechnologyCancer researchPhysicsMetallurgyLanthanide and Transition Metal ComplexesNanoparticle-Based Drug Delivery
Simultaneous enhancement of T<sub>1</sub> and T<sub>2</sub> magnetic resonance imaging of liver tumor at respective low and high magnetic fields | Litcius